UBS’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$15K Buy
41
+10
+32% +$3.66K ﹤0.01% 5571
2014
Q2
$15K Buy
31
+26
+520% +$12.6K ﹤0.01% 5480
2014
Q1
$3K Buy
+5
New +$3K ﹤0.01% 6152
2013
Q4
Sell
-5
Closed -$5K 6576
2013
Q3
$5K Buy
5
+4
+400% +$4K ﹤0.01% 5796
2013
Q2
$1K Buy
+1
New +$1K ﹤0.01% 6118